NP-17

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNP-17
Drug Alias NameNPM-05 seriesalpha-secreatse activators (Noscira)NPM-01NPM-05B1NP-21 +[7] 
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionNeuroprotectantsAlpha secretases stimulants
TargetsAlpha secretases
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNoscira Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNoscira Sa
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A